Tech Company Financing Transactions

Astraveus Funding Round

Astraveus secured a $18 million Seed financing round on 6/27/2023. Backers included AdBio Partners, Bpifrance and Johnson & Johnson Innovation.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1, Avenue Claude Vellefaux Hôpital Saint-Louis, Centre MEARY
Paris, 75010
FR

Phone

Undisclosed

Website

www.astraveus.com

Email Address

[email protected]

Overview

Astraveus is revolutionizing the field of CGT manufacturing with the Lakhesys� platform, an end-to-end, cell foundry, that uses deep process optimization and single-use, microfluidic bioprocessors to deliver better results with reduced inputs. By removing the need for large-scale infrastructure, reducing costs, and overcoming the logistical challenges typically associated with CGT manufacturing, Astraveus is seeking to transform patient access to these life-changing therapies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeremie Laurent

        

Browse more venture capital transactions:

Prev: 6/27/2023: Mythical Games venture capital transaction
Next: 6/27/2023: Resistant AI venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary